Takeda Pharmaceutical. Every tracked FinTwit mention of $TAK, newest first. 13 mentions since the first on Jul 22, 2025. See the price chart.
March 2026 · 1 mention
Mar 6
Jacob Plieth — $DAWN acquisition by Servier for $2.5bn is quite the ending for Ojemda. Who remembers this RAF inhibitor's bizarre & convoluted history? $BIIB $TAK https://t.co/uD5drO9ymr↗
January 2026 · 1 mention
Jan 15
Jacob Plieth — $IVBXF scored with PD-L1 x IL-2, so let's give PD-L1 x IL-12 a go: https://t.co/BhLcVaKhYq And will $TAK pick this one up too?↗
December 2025 · 2 mentions
Dec 12
Jacob Plieth — $BMY sends $PFE $TAK Adcetris a shot across the bows. Via @ApexOnco -> https://t.co/JW2jzGpKHf↗
Dec 12
Jacob Plieth — Hands up who before yesterday had heard of the SWOG S1826 study... 8 Apr 2026 Pdufa date for $BMY Opdivo + chemo in 1L Hodgkin's where it beat $PFE $TAK Adcetris: 3yr PFS FU via Al…↗
November 2025 · 1 mention
Nov 19
Jacob Plieth — $IVBXF CFO Rachel You reckons this is where everyone else went wrong in IL-2 #Jefferies25 $TAK↗
October 2025 · 5 mentions
Oct 22
Jacob Plieth — $IVBXF perseveres with IL-2 cytokine and scores a big deal at last. Some disappointment that this is with $TAK and not a big pharma player? Via @ApexOnco -> https://t.co/U7G0JxK…↗
Oct 22
Jacob Plieth — Pretty amazing run-up by $IVBXF - +135% YTD or +40% since #ASCO25 on the back of IBI363. Does today's $1.2bn up front from $TAK justify the enthusiasm?↗
Jacob Plieth — @jq1234t @ByMadeleineA And guess what the carrying value of $TAK Gammadelta was (not sure the acquisition price had ever been disclosed) https://t.co/ESUJMzrJQC
September 2025 · 2 mentions
Sep 15
Jacob Plieth — My earlier take on this and other ADCs that use Sting agonist payloads, from July: https://t.co/B879yVppH0 $DSNKY $ESALY $EXEL $MKGAF $TAK $MRSN $GSK↗
Sep 8
Adam Feuerstein ✡️ — $ALKS $TAK orexin data presentations from the sleep meeting in Singapore.
Alkermes, Takeda show encouraging data on narcolepsy drugs https://t.co/TJtEk9EgeB via @elaineywchen↗
July 2025 · 1 mention
Jul 22
Adam Feuerstein ✡️ — Drugmakers are racing to help patients stay awake — and could also make billions
A great read from my colleague @elaineywchen reporting on the development of orexin inhibitors $AL…↗